| NICE rejects Kadcyla in final guidance Related items from OnMedica Cancer drug access in England is a ‘debacle’ UK pays less than neighbours for cancer drugs Experts disappointed at NICE decision on ovarian cancer drug Cheap drugs promise reduction in breast cancer deaths The medicine price debate |
Wednesday, 16 December 2015
Breast cancer drug ‘too costly’ for NHS
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment